Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase—a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity - 15/08/11
, Bernhard Przybilla, MD a, Maria Beatrice Biló, MD b, Ulrich Müller, MD c, Fabian Scheipl d, Werner Aberer, MD e, Joëlle Birnbaum, MD f, Anna Bodzenta-Lukaszyk, MD g, Floriano Bonifazi, MD b, Christoph Bucher, MD h, Paolo Campi, MD i, Ulf Darsow, MD j, Cornelia Egger, MD k, Gabrielle Haeberli, MD c, Thomas Hawranek, MD l, Michael Körner, MD m, Iwona Kucharewicz, MD g, Helmut Küchenhoff, PhD d, Roland Lang, PhD l, Oliviero Quercia, MD n, Norbert Reider, MD k, Maurizio Severino, MD i, Michael Sticherling, MD o, Gunter Johannes Sturm, MD e, Brunello Wüthrich, MD hAbstract |
Background |
Severe anaphylaxis to honeybee or vespid stings is associated with a variety of risk factors, which are poorly defined.
Objective |
Our aim was to evaluate the association of baseline serum tryptase concentrations and other variables routinely recorded during patient evaluation with the frequency of past severe anaphylaxis after a field sting.
Methods |
In this observational multicenter study, we enrolled 962 patients with established bee or vespid venom allergy who had a systemic reaction after a field sting. Data were collected on tryptase concentration, age, sex, culprit insect, cardiovascular medication, and the number of preceding minor systemic reactions before the index field sting. A severe reaction was defined as anaphylactic shock, loss of consciousness, or cardiopulmonary arrest. The index sting was defined as the hitherto first, most severe systemic field-sting reaction. Relative rates were calculated with generalized additive models.
Results |
Two hundred six (21.4%) patients had a severe anaphylactic reaction after a field sting. The frequency of this event increased significantly with higher tryptase concentrations (nonlinear association). Other factors significantly associated with severe reactions after a field sting were vespid venom allergy, older age, male sex, angiotensin-converting enzyme inhibitor medication, and 1 or more preceding field stings with a less severe systemic reaction.
Conclusion |
In patients with honeybee or vespid venom allergy, baseline serum tryptase concentrations are associated with the risk for severe anaphylactic reactions. Preventive measures should include substitution of angiotensin-converting enzyme inhibitors.
Le texte complet de cet article est disponible en PDF.Key words : Hymenoptera venom, allergy, anaphylactic shock, tryptase, risk factors, angiotensin-converting enzyme inhibitor, age, sex
Abbreviations used : CE, BTC, EAACI, GAM, ROC, VIT
Plan
| Supported by grants for the collection of the data from Phadia (Freiburg, Germany) and ALK-Abelló (Wedel, Germany). |
|
| Disclosure of potential conflict of interest: F. Ruëff has received lecture honoraria from ALK-Abelló, Phadia, Bencard, and HAL and has received research support from Allergopharma and HAL. B. Przybilla has received research support from Informationsverbund Dermatologischer Kliniken and has provided legal consultation or expert witness testimony on the topic of occupational dermatoses. M. B. Biló has received lecture honoraria from Stallergenes. F. Scheipl has received research support from Deutsche Forschungsgemeinschaft. W. Aberer has received lecture honoraria from ALK-Abelló, Phadia, and Bencard. A. Bodzenta-Lukaszyk and I. Kucharewicz have received honoraria from HAL. F. Bonifazi has received lecture honoraria from Phadia. T. Hawranek has received lecture honoraria and research support from ALK-Abelló. N. Reider has received lecture honoraria and research support from ALK-Abelló, HAL, Bencard, and Phadia. G. J. Sturm has received lecture honoraria from ALK-Abelló. The rest of the authors have declared that they have no conflict of interest. |
Vol 124 - N° 5
P. 1047-1054 - novembre 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
